-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WFfLhWUm6WswQGTPEyz/LFdEjqFduijMtVkDfIKn9K8um7GRNbqDwn2tYethSlAs CN2kEmwF6qHysQg977o03A== 0000950149-01-501271.txt : 20010822 0000950149-01-501271.hdr.sgml : 20010822 ACCESSION NUMBER: 0000950149-01-501271 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20010820 ITEM INFORMATION: Other events FILED AS OF DATE: 20010821 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VARIAN MEDICAL SYSTEMS INC CENTRAL INDEX KEY: 0000203527 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 942359345 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-07598 FILM NUMBER: 1720535 BUSINESS ADDRESS: STREET 1: 3050 HANSEN WAY STREET 2: MAIL STOP E 224 CITY: PALO ALTO STATE: CA ZIP: 94304-1000 BUSINESS PHONE: 6504934000 MAIL ADDRESS: STREET 1: 3050 HANSEN WAY STREET 2: MAIL STOP E 224 CITY: PALO ALTO STATE: CA ZIP: 94304-1000 FORMER COMPANY: FORMER CONFORMED NAME: VARIAN ASSOCIATES INC /DE/ DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: VARIAN DELAWARE INC DATE OF NAME CHANGE: 19761123 8-K 1 f75313e8-k.htm VARIAN MEDICAL SYSTEMS FORM 8-K 8/20/01 Form 8-K
Table of Contents

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

___________

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934


Date of report (Date of earliest event reported) August 20, 2001

Varian Medical Systems, Inc.
(Exact Name of Registrant as Specified in its Charter)


         
Delaware   1-7598   94-2359345
(State or Other Jurisdiction
 
(Commission File
 
(IRS Employer
of Incorporation)
 
Number)
 
Identification No.)

     
3100 Hansen Way, Palo Alto, CA
 
94304-1030
(Address of Principal Executive Offices)
 
(Zip Code)


Registrant’s telephone number, including area code (650) 493-4000

Not Applicable
(Former Name or Former Address, if Changed Since Last Report)


Item 5. Other Events.
Item 7. Financial Statements and Exhibits.
SIGNATURES
EXHIBIT INDEX
Press Release Dated August 20, 2001


Table of Contents

Item 5. Other Events.

     On August 20, 2001, Varian Medical Systems, Inc. (the “Company”) issued a press release announcing that its Board of Directors had authorized the repurchase by the Company of up to one million shares of its stock over the next 12 months. Shares will be retired and cancelled upon repurchase.

     A copy of the press release is attached as an exhibit hereto and is incorporated by reference herein.

Item 7. Financial Statements and Exhibits.

     (c)  Exhibits.

     
99.01   Press Release dated August 20, 2001

2


Table of Contents

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Varian Medical Systems, Inc.
     
     
  By:  /s/ Elisha W. Finney
   
  Name:
Title:
Elisha W. Finney
Vice President,
Finance and Chief Financial Officer

Dated: August 20, 2001

3


Table of Contents

EXHIBIT INDEX

     
Number  
Exhibit

 
99.01
  Press Release dated August 20, 2001


EX-99.01 3 f75313ex99-01.txt PRESS RELEASE DATED AUGUST 20, 2001 1 Exhibit 99.01 FOR INFORMATION CONTACT: Elisha Finney - (650) 424-6803 Spencer Sias - (650) 424-5782 VARIAN MEDICAL SYSTEMS, INC. BOARD OF DIRECTORS AUTHORIZES STOCK REPURCHASE PROGRAM Palo Alto, Calif., August 20, 2001--Varian Medical Systems (NYSE:VAR) today announced that its board has authorized the repurchase by the Company of up to one million shares over the next 12 months. "With cash levels continuing to increase in a low interest rate environment, we expect that these repurchases will be anti-dilutive to earnings," said Richard M. Levy, president and CEO of Varian Medical Systems. "Shareholder value will be enhanced by stock repurchases that help to offset dilution from employee stock option exercises and our employee stock purchase program." The stock repurchase will be made in accordance with applicable state and federal law and in accordance with the terms and subject to the restrictions of Rule 10b-18 under the Securities Exchange Act of 1934, as amended. Shares will be retired and cancelled upon repurchase. FORWARD LOOKING STATEMENTS - -------------------------------------------------------------------------------- Except for historical information, this news release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. For this purpose, statements concerning the anticipated anti-dilutive effect of stock repurchases and any statements using the terms "would," "anticipate," "likely," or similar statements are forward-looking statements that involve risks and uncertainties that could cause our actual results to differ materially from those projected. Such risks and uncertainties include, without limitation, the risks listed from time to time in our filings with the Securities and Exchange Commission. We assume no obligation to, and you should not expect us to, update or revise the forward-looking statements in this release. - -------------------------------------------------------------------------------- # # # VARIAN MEDICAL SYSTEMS, INC., (NYSE:VAR) OF PALO ALTO, CALIFORNIA IS THE WORLD'S LEADING MANUFACTURER OF INTEGRATED CANCER THERAPY SYSTEMS, WHICH ARE TREATING THOUSANDS OF PATIENTS PER DAY. THE COMPANY IS ALSO A PREMIER SUPPLIER OF X-RAY TUBES AND FLAT-PANEL DIGITAL SUBSYSTEMS FOR IMAGING IN MEDICAL SCIENTIFIC, AND INDUSTRIAL APPLICATIONS. VARIAN MEDICAL SYSTEMS EMPLOYS APPROXIMATELY 2,300 PEOPLE WHO ARE LOCATED AT MANUFACTURING SITES IN NORTH AMERICA AND EUROPE AND IN ITS 40 SALES AND SUPPORT OFFICES AROUND THE WORLD. IN ITS MOST RECENT FISCAL YEAR ENDED SEPTEMBER 29, 2000, VARIAN MEDICAL SYSTEMS REPORTED SALES OF $690 MILLION. ADDITIONAL INFORMATION IS AVAILABLE ON THE COMPANY'S INVESTOR RELATIONS WEB SITE AT WWW.VARIAN.COM.
-----END PRIVACY-ENHANCED MESSAGE-----